Atinary Technologies

We are thrilled to announce the strategic collaboration between #Atinary and Takeda, the largest Japanese pharmaceutical company, to drive innovation in healthcare. This partnership brings together our complementary expertise, paving the way for innovative AI solutions poised to transform pharmaceutical R&D and accelerate drug discovery. Through this collaboration, Takeda will leverage Atinary's leading AI Self-Driving Labs technology, that combined with its expertise in R&D and drug discovery aim to create a more robust and efficient drug development process, ultimately benefiting patients worldwide. At Atinary, we are committed to harnessing the power of AI, data science, robotics, and cloud computing to dramatically accelerate the discovery and development of breakthrough molecules. Our collaboration with Takeda Pharmaceuticals is a significant step towards achieving this goal. We look forward to working together to revolutionize the field of drug development and improve healthcare outcomes. Atinary Technologies Inc. https://atinary.com/ Takeda https://www.takeda.com/ #SelfDrivingLabs #SDLabs #AI #ML #Robotics #Cloud #Innovation #Discovery #Acceleration #Molecules #DrugDevelopment #Pharma

🌟 Every journey involves finding the path forward with explorations and unexpected discoveries along the way. In the research journey, scientists balance focused progress with exploration – and Atinary is here to support scientists in their quest for innovation and breakthroughs. 🎯 As we wrap up 2024, we want to extend a heartfelt thank you for your support and for the opportunity to be part of impactful research. Looking ahead to 2025, we remain dedicated to our mission of leveraging #AI and bringing our #SelfDrivingLabs technology, #SDLabs, to transform how science is done - because Science Matters, and together we can accelerate innovation for the good of society. 🚀 We wish you a holiday season filled with peace, joy, and happiness. 🎄🕊️ From all of us at Atinary Technologies

📣 Atinary is delighted to welcome Dr. Paco Laveille to our Scientific Advisory Board! 🚀 Dr. Paco Laveille is a visionary leader in data-driven high-throughput experimentation and catalysis research. He is known for pioneering advancements that merge automated experimentation with AI-driven technologies. As the Managing Director of ETH Zürich’s Swiss Cat+, Dr. Laveille has been at the forefront of transforming scientific research methodologies. "Dr. Paco Laveille's unique blend of technical prowess and execution perfectly aligns with Atinary's mission to accelerate R&D innovation and discovery," said Dr. Hermann Tribukait, Co-Founder and CEO. "His expertise will be invaluable as we expand the collaborations with leading universities and companies to continue pushing the boundaries of what is possible." Dr. Loïc Roch, Co-Founder and CTO, added: “Dr. Laveille’s passion and expertise will help us refine the blueprint for the labs of the future, advancing Atinary’s Self-Driving Lab™ technology at scale. This marks a key milestone in accelerating the discovery of breakthrough molecules and materials.” Reflecting on his appointment, Dr. Paco Laveille said: “I am inspired by Atinary’s commitment to innovation and the potential of its AI and self-driving labs™ technology to revolutionize research. Joining Atinary’s Scientific Advisory Board is an exciting opportunity to advance data-driven high-throughput experimentation not only in catalysis and sustainable technologies but also across diverse scientific fields with meaningful societal impact.” Welcome aboard, Dr. Laveille! Together, we look forward to shaping the future of scientific discovery and innovation. 🚀 More details on Atinary Technologies' website: https://lnkd.in/eHgZ6V3m #AI #MachineLearning #HTE #Catalysis #Sustainability #Innovation #LabAutomation #SelfDrivingLabs #SDLabs #NoCode

🐝 Vancouver is still buzzing with #NeurIPS and the latest in #AI & #ML 🧠 💡 Catch our poster on "Best Practices for Multi-Fidelity Bayesian Optimization (MFBO) in Materials and Molecular Research" at the AI for New Drug Modalities Workshop (AI4DrugX) on Sunday Dec 15. Connect with Atinary’s ML researchers, Víctor Sabanza Gil and Shreyas Padhy, and dive deep into innovative approaches for accelerating scientific discovery with AI! ➡️ Link to article on arXiv: https://lnkd.in/eHWusyCH A collaboration with Profs. Philippe Schwaller and Jeremy Luterbacher from EPFL and Jose Miguel Hernandez Lobato from University of Cambridge. Learn more about Atinary Technologies: https://www.atinary.com #NeurIPS2024 #MachineLearning #BayesianOptimization  #Collaborations #Innovation #MaterialDesign #AIdriven #SelfDrivingLabs #SDLabs #NoCode

🍁 Are you attending #NeurIPS this week? Make sure to connect with Atinary’s ML researchers in Vancouver: Víctor Sabanza Gil and Shreyas Padhy. Our research paper: "Best Practices for Multi-Fidelity Bayesian Optimization (MFBO) in Materials and Molecular Research" will be at the Workshop: AI for New Drug Modalities (AI4DrugX) on Sunday, Dec 15. Learn how to balance between precise but expensive experiments and faster, cost-effective alternatives. 🎯⚖️💲 ➡️ Link to article on arXiv: https://lnkd.in/eHWusyCH Learn more about Atinary Technologies: https://www.atinary.com NeurIPS #NeurIPS2024 #AI #MachineLearning #ML #BayesianOptimization  #Collaborations #Innovation #Technology #MaterialDesign #Acceleration #SelfDrivingLabs #SDLabs #AIdriven #NoCode

We're #hiring a new Sales Account Executive (US) in Boston, Massachusetts. Apply today or share this post with your network.

We're #hiring a new Sales Account Executive (CH) in Epalinges, Vaud. Apply today or share this post with your network.

Last week, I had the pleasure of participating as a speaker and panelist at the #ChemAI Conference in Amsterdam at LAB42 UvA. The atmosphere was electric, bringing together two of my greatest passions: chemistry and artificial intelligence. At Atinary Technologies, we are on a mission to transform how science and R&D are done through our no-code AI platform #SDLabs, which empowers scientists to harness cutting-edge technologies and accelerate groundbreaking discoveries for the good of society. Our team is leading advancements in AI-driven automation, Bayesian optimization, and machine learning—specifically in materials development, small molecule synthesis and process optimization through self-driving labs. Engaging with brilliant minds from industry and academia was truly inspiring. Connecting with fellow innovators who are pushing the boundaries of scientific research reinforced our commitment to transforming the way science is done. Technology isn't about replacing scientists. It's about giving them superpowers 🦸 I am grateful for the opportunity to share our vision and learn from incredible researchers. The future of scientific discovery is AI-driven, collaborative, and incredibly exciting! www.atinary.com Atinary Technologies Avantium Photo credits: #ChemAI, ChemistryNL LAB42 UvA, Amsterdam Science Park, 29 November 2024 © photos www.moniquekooijmans.nl #AI #ML #ChemistryInnovation #Optimization #Sustainability #Innovation #LabAutomation #SelfDrivingLabs #SDLabs #NoCode

We're #hiring a new Sales Account Executive (CH) in Epalinges, Vaud. Apply today or share this post with your network.

It was a pleasure to host Loïc Roch from Atinary Technologies at the high throughput infrastructure at Avantium. He gave an insightful lecture on Self-Driving labs and AI-driven High Throughput Experimentation, followed by a meeting with our team. Loïc's pioneering scientific contributions on #AI, data-driven automation, #Bayesianoptimization and #MachineLearning in the field of materials development and process optimization have attracted considerable attention. Last year, scientific results from a collaboration with ETH-based SwissCat+ led to the company adding their #ML knowledge to Flowrence high throughput data of fixed-bed catalysis and automated inorganic synthesis robots by Chemspeed. See for details of the Swiss Cat+ infrastructure: Chimia 2023, 77, 154  https://lnkd.in/ekiUPgfq And for the results based on the SwissCat+ infrastructure and Atinary Technologies applied to #CO2 hydrogenation: Chem Catalysis, Volume 4, Issue 2, 100888 https://lnkd.in/eza83FqU Hermann Tribukait Paco Laveille Adrian Ramirez Galilea Chemspeed Arunraj Chidambaram Dr Amira Abou-Hamdan ChemAI Tiago Vilela Peter Flippo Maurice Mourad